Search results for "From ACP Internist"


 
Results 81 - 85 of about 85 for "From ACP Internist".
Sort by: Relevance | Newest | Oldest

Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find

A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://diabetes.acponline.org/archives/2022/10/14/8.htm
14 Oct 2022

Some newer diabetes drugs may help decrease risk of COPD exacerbation

A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://diabetes.acponline.org/archives/2022/11/11/6.htm
11 Nov 2022

Racial, economic disparities found in use of SGLT2 inhibitors

Although use of sodium-glucose cotransporter-2 (SGLT2) inhibitors rose overall between 2015 and 2019, patients who were Black, Asian, female, or with lower household income had lower rates of prescriptions for the drug class than others with type 2 diabetes.
https://diabetes.acponline.org/archives/2021/05/14/8.htm
14 May 2021

USPSTF lowers age for starting diabetes screening from 40 to 35 years

Primary care clinicians should screen all overweight or obese adults ages 35 to 70 years for diabetes and prediabetes and should offer interventions for those with either condition, the U.S. Preventive Services Task Force (USPSTF) recently recommended.
https://diabetes.acponline.org/archives/2021/09/10/6.htm
10 Sep 2021

SGLT2 inhibitors associated with rare, life-threatening necrotizing genital infections

In the past six years, nearly three times as many cases of Fournier gangrene were reported in patients taking sodium-glucose cotransporter-2 (SGLT2) inhibitors as in the past 35 years in patients taking other antiglycemic agents.
https://diabetes.acponline.org/archives/2019/05/10/11.htm
10 May 2019

Result Page: Prev   4   5   6   7   8   9   Next